180 related articles for article (PubMed ID: 16515984)
1. Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer.
Freedland SJ; Kane CJ; Amling CL; Aronson WJ; Presti JC; Terris MK;
J Urol; 2006 Apr; 175(4):1298-302; discussion 1302-3. PubMed ID: 16515984
[TBL] [Abstract][Full Text] [Related]
2. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
Bastian PJ; Gonzalgo ML; Aronson WJ; Terris MK; Kane CJ; Amling CL; Presti JC; Mangold LA; Humphreys E; Epstein JI; Partin AW; Freedland SJ
Cancer; 2006 Sep; 107(6):1265-72. PubMed ID: 16900523
[TBL] [Abstract][Full Text] [Related]
4. Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml.
Makarov DV; Humphreys EB; Mangold LA; Walsh PC; Partin AW; Epstein JI; Freedland SJ
J Urol; 2006 Aug; 176(2):554-8. PubMed ID: 16813888
[TBL] [Abstract][Full Text] [Related]
5. Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score?
Fitzsimons NJ; Presti JC; Kane CJ; Terris MK; Aronson WJ; Amling CL; Freedland SJ
J Urol; 2006 Dec; 176(6 Pt 1):2453-8; discussion 2458. PubMed ID: 17085127
[TBL] [Abstract][Full Text] [Related]
6. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database.
Scales CD; Presti JC; Kane CJ; Terris MK; Aronson WJ; Amling CL; Freedland SJ;
J Urol; 2007 Oct; 178(4 Pt 1):1249-52. PubMed ID: 17698131
[TBL] [Abstract][Full Text] [Related]
7. Reasonable delay of surgical treatment in men with localized prostate cancer--impact on prognosis?
Graefen M; Walz J; Chun KH; Schlomm T; Haese A; Huland H
Eur Urol; 2005 Jun; 47(6):756-60. PubMed ID: 15925069
[TBL] [Abstract][Full Text] [Related]
8. PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database.
Freedland SJ; Hotaling JM; Fitzsimons NJ; Presti JC; Kane CJ; Terris MK; Aronson WJ; Amling CL
Eur Urol; 2008 Apr; 53(4):758-64; discussion 765-6. PubMed ID: 17868976
[TBL] [Abstract][Full Text] [Related]
9. Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center.
Freedland SJ; Grubb KA; Yiu SK; Humphreys EB; Nielsen ME; Mangold LA; Isaacs WB; Partin AW
J Urol; 2005 Sep; 174(3):919-22. PubMed ID: 16093988
[TBL] [Abstract][Full Text] [Related]
10. Is a positive bladder neck margin truly a T4 lesion in the prostate specific antigen era? Results from the SEARCH Database.
Buschemeyer WC; Hamilton RJ; Aronson WJ; Presti JC; Terris MK; Kane CJ; Amling CL; Freedland SJ
J Urol; 2008 Jan; 179(1):124-9; discussion 129. PubMed ID: 17997433
[TBL] [Abstract][Full Text] [Related]
11. Changing nature of high risk patients undergoing radical prostatectomy.
Kane CJ; Presti JC; Amling CL; Aronson WJ; Terris MK; Freedland SJ;
J Urol; 2007 Jan; 177(1):113-7. PubMed ID: 17162017
[TBL] [Abstract][Full Text] [Related]
12. Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?
Boorjian SA; Bianco FJ; Scardino PT; Eastham JA
BJU Int; 2005 Oct; 96(6):773-6. PubMed ID: 16153197
[TBL] [Abstract][Full Text] [Related]
13. Pathological features after radical prostatectomy in potential candidates for active monitoring.
Griffin CR; Yu X; Loeb S; Desireddi VN; Han M; Graif T; Catalona WJ
J Urol; 2007 Sep; 178(3 Pt 1):860-3; discussion 863. PubMed ID: 17631347
[TBL] [Abstract][Full Text] [Related]
14. Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality.
Freedland SJ; Humphreys EB; Mangold LA; Eisenberger M; Partin AW
J Urol; 2006 Oct; 176(4 Pt 1):1404-8. PubMed ID: 16952644
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
[TBL] [Abstract][Full Text] [Related]
16. Obesity and capsular incision at the time of open retropubic radical prostatectomy.
Freedland SJ; Grubb KA; Yiu SK; Nielsen ME; Mangold LA; Isaacs WB; Epstein JI; Partin AW
J Urol; 2005 Nov; 174(5):1798-801; discussion 1801. PubMed ID: 16217290
[TBL] [Abstract][Full Text] [Related]
17. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.
Magheli A; Rais-Bahrami S; Carter HB; Peck HJ; Epstein JI; Gonzalgo ML
J Urol; 2007 Oct; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121
[TBL] [Abstract][Full Text] [Related]
18. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H
BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
[TBL] [Abstract][Full Text] [Related]
19. Percent tumor involvement and risk of biochemical progression after radical prostatectomy.
Rampersaud EN; Sun L; Moul JW; Madden J; Freedland SJ
J Urol; 2008 Aug; 180(2):571-6; discussion 576. PubMed ID: 18554662
[TBL] [Abstract][Full Text] [Related]
20. Stronger association between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 years.
Freedland SJ; Isaacs WB; Mangold LA; Yiu SK; Grubb KA; Partin AW; Epstein JI; Walsh PC; Platz EA
Clin Cancer Res; 2005 Apr; 11(8):2883-8. PubMed ID: 15837737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
